| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 07/14/2004 | EP1436269A1 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1436268A1 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them |
| 07/14/2004 | EP1436257A1 Low-calcemic oxime analogs of 1alpha, 25-dihydroxy vitamin d3 |
| 07/14/2004 | EP1436255A1 Novel compounds and compositions as cathepsin inhibitors |
| 07/14/2004 | EP1436252A1 Hydroxyfattysulfonic acid analogs |
| 07/14/2004 | EP1436247A1 Novel-beta-phenyl-alpha-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds |
| 07/14/2004 | EP1436008A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 07/14/2004 | EP1435984A1 Use of histamine to treat liver disease |
| 07/14/2004 | EP1435950A1 2'-methyl-5'-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435949A1 2' -methyl-5-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435948A1 Aminoisoxazole derivatives active as kinase inhibitors |
| 07/14/2004 | EP1435946A2 Linked biaryl compounds |
| 07/14/2004 | EP1435942A1 5'-carbamoyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435934A1 5'-acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435933A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435930A2 Anti-glycation agents for preventing age-, diabetes-, and smoking-related complications |
| 07/14/2004 | EP1435925A2 Gap junctions and edhf |
| 07/14/2004 | EP1435894A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 07/14/2004 | EP1435826A2 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 07/14/2004 | EP1365760A4 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 07/14/2004 | EP1254120B1 Use of pyrimidine endothelin antagonists in companion animals |
| 07/14/2004 | EP1235803B1 Urea compounds having muscarinic receptor antagonist activity |
| 07/14/2004 | EP1228067B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 07/14/2004 | EP1224179B1 Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 07/14/2004 | CN1512985A Aimoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands |
| 07/14/2004 | CN1512983A Compounds and compositions as cathepsins inhibitors |
| 07/14/2004 | CN1512888A Modified proteins, designer toxins and methosd of making thereof |
| 07/14/2004 | CN1512880A Novel compounds and compositions as cathepsin inhibitors |
| 07/14/2004 | CN1511830A Compound used as antiphlogistic |
| 07/14/2004 | CN1511581A Stone expelling drink |
| 07/14/2004 | CN1511573A Medicinal composition for preventing and curing prostatitis and hyperplasia of prostate and its preparing method |
| 07/14/2004 | CN1511523A New use of bergenin in treating chronic prostatitis and proliferative diseases |
| 07/14/2004 | CN1157224C Novel amide derives. as growth hormone secretagogues |
| 07/14/2004 | CN1157187C Remedies for renal failure |
| 07/13/2004 | US6762200 Phospholipase inhibitors |
| 07/13/2004 | US6762196 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase |
| 07/13/2004 | US6762176 Inhibiting no-synthase enzymes producing nitrogen monoxide and/or trapping reactive forms of oxygen; inhibit lipidic peroxidation |
| 07/13/2004 | US6761885 Used for treating and/or preventing urogenital infections |
| 07/08/2004 | WO2004056811A1 Flavaxate derivatives as muscarinic receptor antagonists |
| 07/08/2004 | WO2004056768A2 Use of substituted 2,5-diamidoindoles for the treatment of urological diseases |
| 07/08/2004 | WO2004056767A1 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists |
| 07/08/2004 | WO2004056380A2 Composition comprising plant extract and a sugar for use in inhibiting bacterial proliferation |
| 07/08/2004 | WO2004056376A1 Pharmaceutical formulations containing nitrate |
| 07/08/2004 | WO2004056354A1 Controlled release pharmaceutical compositions of tamsulosin |
| 07/08/2004 | WO2003105771A3 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
| 07/08/2004 | WO2003103663A3 Substituted pyrrolines as kinase inhibitors |
| 07/08/2004 | WO2003070918A3 Rna interference by modified short interfering nucleic acid |
| 07/08/2004 | WO2003053292B1 Vaginal delivery of drugs |
| 07/08/2004 | WO2003042358A3 Methods of using 48149, a human aminopeptidase family member |
| 07/08/2004 | WO2003039553B1 Compositions for treatment of postmenopausal female sexual dysfunction |
| 07/08/2004 | WO2002097060A3 Carbohydrate-associated proteins |
| 07/08/2004 | US20040132829 Urogenital disorders |
| 07/08/2004 | US20040132822 Crystalline solid form of (2S,5Z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 07/08/2004 | US20040132805 preferably also contains a compound that donates, transfers, releases or induces production of nitric oxide and a hydralazine antioxidant; for treating and/or preventing a vascular disease characterized by nitric oxide insufficiency |
| 07/08/2004 | US20040132797 treating of or preventing relapse of depression, anxiety disorders, eating disorders, or urinary incontinence |
| 07/08/2004 | US20040132781 Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2004 | US20040132768 substituted with (hetero)aryl carbonyloxy group and quaternized, e.g., 3(R)-Diphenylacetoxy-1-(3-phenoxy-propyl)-1-azoniabicyclo[2.2.2]octane; bromide; antimuscarinic agents for treating COPD, chronic bronchitis, asthma and rhinitis. |
| 07/08/2004 | US20040132757 Triazospiro compounds having nociceptin receptor affinity |
| 07/08/2004 | US20040132736 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 07/08/2004 | US20040132729 Inhibitors of p38 |
| 07/08/2004 | US20040132725 tyrphostin preparations enriched in certain geometric isomers; treating protein tyrosine kinase related disorders. especially with slow release formulations |
| 07/08/2004 | US20040132710 Lactams as tachkinin antagonists |
| 07/08/2004 | US20040132694 6-Chloro-3-(3,4-dioxo-2-phenylamino-cyclobut-1-enylamino)-2-hydroxy-benzamide; psoriasis, atopic dermatitis, arthritis, asthma, chronic obstructive pulmonary disease, adult respiratory distress syndrome, inflammatory bowel disease, Crohn's disease |
| 07/08/2004 | US20040132641 Fas peptide mimetics and uses thereof |
| 07/08/2004 | US20040132636 Pharmaceutical uses for alpha2delta ligands |
| 07/08/2004 | US20040132635 Method for prevention and treatment of kidney diseases |
| 07/08/2004 | US20040132163 Biological materials and uses thereof |
| 07/08/2004 | US20040132038 Membrane protein for use as diagnostic tool in the detection and prevention of cell proliferative, cardiovascular, skin, nervous system, respiratory and metabolic disorders |
| 07/08/2004 | US20040131703 Antiinflammatory agents; respiratory system disorders |
| 07/08/2004 | US20040131694 Mixture of polysaccharides, thymus and prostate extract, carbohydrates in solvent; freezing, storage |
| 07/08/2004 | CA2511208A1 Controlled release pharmaceutical compositions of tamsulosin |
| 07/08/2004 | CA2510811A1 Use of substituted 2,5-diamidoindoles for the treatment of urological diseases |
| 07/07/2004 | EP1435387A1 The oncolytic microorganisms expressing hsp and uses thereof |
| 07/07/2004 | EP1435353A1 Novel heterocyclic compound and anti-inflammatory agent |
| 07/07/2004 | EP1435235A1 Use of hydroxyoleic acid and similar compounds in the production of medicaments |
| 07/07/2004 | EP1434990A2 Method for identifying compounds the specifically deplete mast cells |
| 07/07/2004 | EP1434863A1 IDENTIFICATION AND USE OF MAMMALIAN p21 INHIBITORS |
| 07/07/2004 | EP1434860A2 Enzymes |
| 07/07/2004 | EP1434798A2 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival of cells |
| 07/07/2004 | EP1434796A2 Secreted proteins |
| 07/07/2004 | EP1434792A2 Peptidyl ketones as inhibitors of dpiv |
| 07/07/2004 | EP1434788A2 Proteins associated with cell growth, differentiation, and death |
| 07/07/2004 | EP1434775A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists |
| 07/07/2004 | EP1434769A2 Compounds useful as reversible inhibitors of cysteine proteases |
| 07/07/2004 | EP1434763A2 Beta-lactamyl vasopressin v1a antagonists |
| 07/07/2004 | EP1434599A1 Human 3 relaxin |
| 07/07/2004 | EP1434594A1 Cyclosporin analogs for the treatment of autoimmune diseases |
| 07/07/2004 | EP1434583A1 N-aroyl piperazine derivatives as orexin receptor antagonists |
| 07/07/2004 | EP1434577A1 Pyrrolidinone derivatives |
| 07/07/2004 | EP1434575A1 Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites |
| 07/07/2004 | EP1434570A1 Pharmaceutical formulations for the controlled release of 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline |
| 07/07/2004 | EP0946552B1 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 07/07/2004 | CN1511159A Nitrogen-based camptothecin derivatives |
| 07/07/2004 | CN1511157A Novel pyrrole derivatives as pharmaceutical agents |
| 07/07/2004 | CN1511038A Combination therepy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 07/07/2004 | CN1509756A Chinese medicine 'Shentiansu' for internal organ diseases |
| 07/07/2004 | CN1509739A Chinese medicinal composition for chronic primary glomerulonephritis and its preparation and quality control |
| 07/07/2004 | CN1156452C Compound as anti-inflammatory agent |
| 07/07/2004 | CN1156294C Stone cleaning liquid for curing stone disease of urinary system |
| 07/07/2004 | CN1156282C 活性山羊血粉胶囊 Activity goat blood meal capsule |